GTx, Inc. (GTXI) financial statements (2021 and earlier)

Company profile

Business Address 12230 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1172028442229
Cash and cash equivalents117202816914
Short-term investments  0281315
Prepaid expense1     
Other undisclosed current assets 13223
Total current assets:1182131462432
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment  0000
Intangible assets, net (including goodwill)  000 
Intangible assets, net (excluding goodwill)  000 
Other noncurrent assets11    
Other undisclosed noncurrent assets     0
Total noncurrent assets:110000
TOTAL ASSETS:1192231462532
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities443310
Accounts payable113310
Accrued liabilities33    
Employee-related liabilities  0000
Debt 0    
Other undisclosed current liabilities2425330
Total current liabilities:6758530
Noncurrent Liabilities
Long-term debt and lease obligation 0    
Operating lease, liability 0
Total noncurrent liabilities: 0    
Total liabilities:6758530
Stockholders' equity
Stockholders' equity attributable to parent113142638202
Common stock000000
Additional paid in capital19680626600551515
Accumulated deficit(83)(66)(600)(562)(531)(513)
Total stockholders' equity:113142638202
TOTAL LIABILITIES AND EQUITY:1192231462532

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:32    
Operating expenses(21)(36)(39)(31)(26)(22)
Operating loss:(18)(33)(39)(31)(26)(22)
Nonoperating income (expense)0(1)1000
Other nonoperating income (expense)0(1)1000
Loss before gain (loss) on sale of properties:(17)(34)(38)(30)(26)(22)
Other undisclosed net loss(0)     
Net loss:(17)(34)(38)(30)(26)(22)
Other undisclosed net income attributable to parent    83
Net loss available to common stockholders, basic:(17)(34)(38)(30)(18)(19)
Other undisclosed net loss available to common stockholders, diluted     (3)
Net loss available to common stockholders, diluted:(17)(34)(38)(30)(18)(22)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(17)(34)(38)(30)(26)(22)
Comprehensive loss, net of tax, attributable to parent:(17)(34)(38)(30)(26)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: